-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GuEIZ8lU6qx3UIKtkRbOg2LHPDEn7x0s+JjGbLzPgoM8wKcYRuA5z8+UHpUX38Oy
 plUMwBpS9Gb+It0mFx2Abg==

<SEC-DOCUMENT>9999999997-02-010419.txt : 20020414
<SEC-HEADER>9999999997-02-010419.hdr.sgml : 20020414
<PAPER>
ACCESSION NUMBER:		9999999997-02-010419
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20020213

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VISIBLE GENETICS INC
		CENTRAL INDEX KEY:			0001010819
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-49801
		FILM NUMBER:		02016466

	BUSINESS ADDRESS:	
		STREET 1:		700 BAY ST
		STREET 2:		SUITE 1000
		CITY:			TORONTO ONTARIO CANA
		STATE:			A6
		ZIP:			00000
		BUSINESS PHONE:		2127025700

	MAIL ADDRESS:	
		STREET 1:		700 BAY ST STE 1000
		STREET 2:		TORONTO ONTARIO CANADA
		CITY:			M5G 1Z6
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>9999999997-02-010419.paper
<DESCRIPTION>AUTO-GENERATED PAPER DOCUMENT
<TEXT>
This document was generated as part of a paper submission.
Please reference the Document Control Number 02016466 for access to the original document.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----